Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7884111 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

Patent 7884111 was granted and assigned to Rigel Pharmaceuticals on February, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071432 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
0
Edits on 27 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 27 Nov, 2023
Edits made to:
Article (+284 characters)
Article

Patent abstract

The present invention provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.

Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0788411100
Edits on 20 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07884111 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents US Patent 7884111 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

Infobox
Patent Number
0788411100
Patent Number
788411100
Edits on 28 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Rigel Pharmaceuticals
Rigel Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
078841110
Date of Patent
February 8, 2011
0
Patent Application Number
115678200
Date Filed
December 7, 2006
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=078841110
Patent Primary Examiner
‌
Johann R. Richter
0
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Rigel Pharmaceuticals
Rigel Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
078841110
Date of Patent
February 8, 2011
0
Patent Application Number
115678200
Date Filed
December 7, 2006
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=078841110
Patent Primary Examiner
‌
Johann R. Richter
0
Edits on 4 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 4 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07884111
Edits on 6 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 6 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07884111 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

Infobox
Is a
Patent
Patent
Current assignee
Rigel Pharmaceuticals
Rigel Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07884111
Date of patent
February 8, 2011
Patent application number
11567820
Date Filed
December 7, 2006
Patent primary examiner
‌
Johann R. Richter

Find more entities like US Patent 7884111 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.